The Xalud directors bring their valued perspectives and experiences to guide the development of Xalud Therapeutics, Inc.
Stephen Collins, MD/PhD, Chairman
Dr. Collins has extensive experience managing biopharmaceutical companies and leading pain and CNS drug development efforts. He served as Senior Director for Global CNS and Pain at Johnson and Johnson and Chief Scientific Officer and Vice President of Medical Affairs at Ovation Pharmaceuticals (acquired by Lundbeck for approximately $963 MM). Most recently he served as Chief Executive Officer of NeuroTherapeutics Pharma, Inc., a venture-backed biotechnology company developing treatments for pain and epilepsy.
Jayson Rieger, PhD/MBA, Principal, PBM Capital Group
Jayson Rieger is currently a Principal at PBM Capital Group where he supports new investment evaluation, deal sourcing and provides technical and business support for portfolio companies. Dr. Rieger has about 15 years experience in cross-functional scientific and business leadership roles spanning business development, research operations, drug discovery and product development in the life sciences industry. He is an entrepreneurial-minded scientist and business leader with material involvement in multiple successful investor exits. Most recently he served as Corporate Senior Vice President and President of the Human Therapeutics Division at Intrexon Corporation, a synthetic biology company that had an IPO in August 2013 (NYSE: XON). Dr. Rieger has also served as the Vice President of Research and Virginia Operations for Clinical Data, Inc. (NSDQ: CLDA), prior to its acquisition by Forest Labs in 2011. Jayson has also held the role of Vice President of Lead Development at Adenosine Therapeutics, LLC, prior to its acquisition by Clinical Data in 2008.
Dr. Rieger has delivered a number of invited lectures at universities and scientific conferences and has served as a key team member in multiple development programs ranging from discovery stage research to Phase III clinical trials. He is the recipient of more than 10 federal grants, serving as both principal and co-investigator on efforts targeted towards evaluating adenosine receptor agents in a variety of disease indications. He is a co-inventor on more than 25 patents and has authorship on more than 25 peer-reviewed scientific publications.
Dr. Rieger obtained his Ph.D. from the University of Virginia in Chemistry, has an MBA from the Darden Business School and earned his B.A. from Rollins College.
Sean Stalfort, Principal, PBM Capital Group
Sean Stalfort is a Principal at PBM Capital Group where he sources and structures new investment opportunities and oversees many of the portfolio companies. Prior to joining PBM Capital, Sean was the Executive Vice President for New Business Development/M&A for PBM Products where he sourced and managed new growth opportunities internationally as well as various capital market activities through the sale of the company to Perrigo.
Sean has been an entrepreneur since the age of 15 and enjoys working with inventors, scientists and other entrepreneurs to realize dreams and create dynamic companies. At PBM Capital, Sean leverages PBM’s core competencies in sales, marketing and distribution to partner with entrepreneurs and provide the necessary resources, knowledge and capital to maximize growth.
Sean is also a founding partner of Octagon Partners and Octagon Capital Partners, value-oriented real estate investment and development firms focused on tax credit deals in college towns throughout the country.
Previously, Sean was a Managing Director and founding partner in Ravelin Capital and Benevolent Capital, private equity investment companies providing capital to companies within niche value-add industries. From 1997 to 2000, Sean was a founding principal and Senior Vice President of Capital Markets in Enterprise Mortgage, a specialty finance company which provided over $1.5 billion in senior cash flow debt financing to small and mid-sized companies and properties.
From 1995 to 1997, Sean was a Vice President in Greenwich Capital’s Asset-Backed Finance Group where he structured over $2 billion in various securitized transactions. In 1993, he joined Greenwich Capital Markets as a Senior Underwriter in the Commercial Finance Group. Sean started his career as an investment banking associate at CS First Boston in New York.
Sean graduated from Brown University (B.A., Business Economics, Political Science, 1991). He is a member of YPO (Young Presidents Organization) and sits on the Board of several charities including the Ronald McDonald House. He is married to his high school sweetheart and has three amazing boys. He enjoys coaching and playing lacrosse, challenging exercise programs, and having fun with the family.